Dalal, M. A., Schuld, A., & Pollmächer, T. (2003). Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Pharmacopsychiatry, 36(5), 218-218.